Literature DB >> 22904176

Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas.

Francesco Bertagna1, Giorgio Treglia, Arnoldo Piccardo, Raffaele Giubbini.   

Abstract

CONTEXT: Thyroid incidentaloma diagnosed by 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (F-18-FDG-PET/CT) is defined as a thyroid uptake incidentally and newly detected in a patient studied for nonthyroid purpose. In this review, we have comprehensively analyzed the diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas revealed during studies performed for an unrelated and nonthyroid purpose. EVIDENCE ACQUISITION: A comprehensive literature research of the PubMed/MEDLINE databases was conducted to find relevant published articles about the F-18-FDG-PET or F-18-FDG-PET/CT thyroid incidentalomas. EVIDENCE SYNTHESIS: All studies considered in this review have investigated a very large number of patients, achieving overall about 147,505 units. The pooled incidence of thyroid incidentalomas detected by F-18-FDG-PET or PET/CT was 2.46% (95% confidence interval, 1.68-3.39%). The malignancy ratio was 34.6% (95% confidence interval, 29.3-40.2%).
CONCLUSION: F-18-FDG-PET/CT thyroid incidentaloma is a relevant clinical finding; diffuse uptakes and most focal uptakes are commonly caused by benign diseases, whereas about one third of focal uptakes are malignant; the most frequent malignant histological type responsible for F-18-FDG-PET/CT thyroid incidentaloma is papillary thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22904176     DOI: 10.1210/jc.2012-2390

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  48 in total

1.  Multicentre study of 18F-FDG-PET/CT prostate incidental uptake.

Authors:  Francesco Bertagna; Arnoldo Piccardo; Bassam Dib; Mattia Bertoli; Federica Fracassi; Giovanni Bosio; Raffaele Giubbini; Giorgio Biasiotto; Luca Giovanella; Giorgio Treglia
Journal:  Jpn J Radiol       Date:  2015-07-08       Impact factor: 2.374

2.  Thyroid metastasis from breast cancer detected by 18F-FDG PET/CT.

Authors:  Rexhep Durmo; Domenico Albano; Raffaele Giubbini
Journal:  Endocrine       Date:  2019-04-01       Impact factor: 3.633

3.  Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ¹⁸F-FDG PET Study.

Authors:  James Nagarajah; Alan L Ho; R Michael Tuttle; Wolfgang A Weber; Ravinder K Grewal
Journal:  J Nucl Med       Date:  2015-03-26       Impact factor: 10.057

4.  Role of multi-modality functional imaging in differentiation between benign and malignant thyroid 18F-fluorodeoxyglucose incidentaloma.

Authors:  H Shi; Z Yuan; C Yang; J Zhang; C Liu; J Sun; X Ye
Journal:  Clin Transl Oncol       Date:  2019-03-29       Impact factor: 3.405

5.  Feasibility of FDG-PET/CT for the initial diagnosis of papillary thyroid cancer.

Authors:  Heejin Kim; Kyung Jin Na; Jae Hyuk Choi; Byeong-Cheol Ahn; Dongbin Ahn; Jin Ho Sohn
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

6.  Recurrent lymphoma in the thyroid gland detected by fluorine-18-fluorodeoxyglucose PET/CT.

Authors:  Giorgio Treglia; Annemilia Del Ciello; Davide Di Franco
Journal:  Endocrine       Date:  2012-09-05       Impact factor: 3.633

7.  Relationship Between 18F-fluorodeoxyglucose Accumulation and the BRAF V600E Mutation in Papillary Thyroid Cancer.

Authors:  Jae Won Chang; Ki Wan Park; Jae Hyung Heo; Seung-Nam Jung; Lihua Liu; Sung Min Kim; In Sun Kwon; Bon Seok Koo
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

8.  A Papillary Thyroid Tumor Detected by (18)F-FDG-PET/CT in a Pediatric Patient with Cowden Syndrome.

Authors:  Giorgio Treglia; Carmelo Caldarella; Paola Castaldi; Barbara Muoio; Francesco Bertagna; Luca Giovanella
Journal:  Nucl Med Mol Imaging       Date:  2012-11-23

Review 9.  Prevalence and clinical significance of incidental F18-FDG breast uptake: a systematic review and meta-analysis.

Authors:  Francesco Bertagna; Giorgio Treglia; Emanuela Orlando; Lodovica Dognini; Luca Giovanella; Ramin Sadeghi; Raffaele Giubbini
Journal:  Jpn J Radiol       Date:  2013-12-13       Impact factor: 2.374

10.  Correlation of BRAF mutation and SUVmax levels in thyroid cancer patients incidentally detected in 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Aysenur Ozderya; Sule Temizkan; Aylin Ege Gul; Sule Ozugur; Mehmet Sargin; Kadriye Aydin
Journal:  Endocrine       Date:  2016-10-01       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.